Andrea Palloni - Sant'Orsola-Malpighi Hospital, University of Bologna

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 99 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Management of Portal Hypertension in Patients Receiving Atezolizumab-Bevacizumab for Hepatocellular Carcinoma

F. Tovoli,E. Franceschini,C. Vivaldi,P. Federico,A. Palloni,A. Dalbeni,C. Solda,B. Stefanini,I. Garajova,L. Ielasi,S. De Lorenzo,A. Granito, R. Chen,G. Masi,S. Lonardi,G. Brandi,B. Daniele,D. Sacerdoti,L. Lani,G. Svegliati-Baroni, C. Campani, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S87-S87

引用0浏览0引用

Activated FGFR2 Signalling As a Biomarker for Selection of Intrahepatic Cholangiocarcinoma Patients Candidate to FGFR Targeted Therapies

Giovanni Brandi,Valeria Relli,Marzia Deserti,Andrea Palloni,Valentina Indio,Annalisa Astolfi,Salvatore Serravalle,Alessandro Mattiaccio,Francesco Vasuri,Deborah Malvi,Chiara Deiana,Maria Abbondanza Pantaleo,Matteo Cescon,Alessandro Rizzo,Masaru Katoh,Simona Tavolari

SCIENTIFIC REPORTSno. 1 (2024)

引用0浏览0WOSNATURE引用

Efficacy and Safety of Atezolizumab/bevacizumab for Hepatocellular Carcinoma in a Real-Life Prospective Cohort: Data from a Multicenter Collaborative Study

F. Tovoli,C. Vivaldi,P. Federico,B. Stefanini,A. Palloni,A. Dalbeni,C. Solda,L. Lani,I. Garajova,S. Tamberi,S. De Lorenzo,A. Granito, D. P. Pallotta,G. Masi,S. Lonardi,G. Brandi,B. Daniele,D. Sacerdoti,G. Svegliati-Baroni, C. Campani, E. Pellegrini, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S85-S86

引用0浏览0引用

Aetiology of Hepatocellular Carcinoma and Response to Immunotherapy: is the Problem Inherent in the Classification of Non-Viral Disease

F. Tovoli, R. Chen,C. Vivaldi,P. Federico,A. Palloni,L. A. Natola,C. Solda,B. Stefanini,I. Garajova,L. Ielasi,S. De Lorenzo,A. Granito, G. Monaco,G. Masi,S. Lonardi,G. Brandi,B. Daniele,A. Dalbeni,L. Lani,G. Svegliati-Baroni, C. Campani, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S92-S93

引用0浏览0引用

The Impact of Etiology on Patterns of Progression of Advanced HCC

B. Stefanini,F. Piscaglia,A. Dalbeni,C. Vivaldi,P. Federico,A. Palloni,C. Solda,I. Garajova,L. Ielasi,S. De Lorenzo,G. Masi,S. Lonardi,G. Brandi,B. Daniele,F. Trevisani,G. Svegliati-Baroni,C. Campani, R. Chen,F. Tovoli

DIGESTIVE AND LIVER DISEASE (2024): S17-S17

引用0浏览0引用

Pemigatinib for Patients with Previously Treated, Locally Advanced or Metastatic Cholangiocarcinoma Harboring FGFR2 Fusions or Rearrangements: A Joint Analysis of the French PEMI-BIL and Italian PEMI-REAL Cohort Studies

EUROPEAN JOURNAL OF CANCER (2024)

引用0浏览0WOS引用

Decreasing Albumin Mrna Expression in Cholangiocarcinomas along the Bile Duct Tree

Elisa Albertini,Stefano Chillotti, Giada Monti,Deborah Malvi,Marzia Deserti,Alessio Degiovanni,Andrea Palloni,Simona Tavolari,Giovanni Brandi,Antonia D'Errico,Francesco Vasuri

PATHOBIOLOGY（2024）

引用0浏览0WOS引用

SAT-477-YI the Impact of Etiologyon Patterns of Progression of Advanced HCC

Bernardo Stefanini, Fabio Piscaglia,Andrea Dalbeni,Caterina Vivaldi,Piera Federico,Andrea Palloni,Caterina Soldà,Benedetta Stefanini,Ingrid Garajová,Luca Ielasi,Stefania De Lorenzo, Gianluca Masi, Sara Lonardi,Giovanni Brandi, Bruno Daniele,Franco Trevisani,Gianluca Svegliati‐Baroni,Claudia Campani,Rusi Chen, Francesco Tovoli

Journal of hepatology (2024): S395-S395

引用0浏览0引用

Sorafenib As a Second-Line Treatment after Failure of Atezolizumab-Bevacizumab

F. Tovoli, M. Boe,C. Vivaldi,P. Federico,A. Palloni,A. Dalbeni,C. Solda,B. Stefanini,I. Garajova,L. Ielasi,S. De Lorenzo,A. Granito,G. Masi,S. Lonardi,G. Brandi,B. Daniele,A. Auriemma,L. Lani,G. Svegliati-Baroni, C. Campani, F. Piscaglia

DIGESTIVE AND LIVER DISEASE (2024): S79-S79

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn